ARCHIVES

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

This article is from The Cancer Letter archive.

Vol. 40 No. 06 | February 7, 2014

Download PDF Visit The Full Archive

Related Articles

Study Sheds Light On How NSAIDS Prevent Colon Cancer

April 25, 2003

HCFA Disregards Pleas From Centers, ACCC, Sen. Dole, NCAB, AACI; Final DRG Regulations Made Even Tougher

January 13, 1984

ACS Reports Breast Cancer Incidence At All Time High

January 23, 1987

In Brief: NCI’s Cutler Clarifies Policy On Release Of Survey Data, Tape Duplicates Will Be Available At Cost

September 6, 1974

Amid Protests Over Grant Paylines, NCI’s Niederhuber Tells Scientists To Get “Leaner And Better”.

April 7, 2006

GM Honors Blackburn, Kuhl, Phelps, Speizer, And Willett

June 8, 2001